Guk Jin Lee

Guk Jin Lee

Auto-generated profile, based on publicly available information

Guk Jin Lee

Division of Medical Oncology, Department of Internal Medicine, Bucheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2024 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
CLCheol-Jung Lee
Cheol-Jung Lee
HLHeejung Lee
Heejung Lee
SKSeo Ree Kim
Seo Ree Kim
SNSoo-Bin Nam
Soo-Bin Nam
GLGa-Eun Lee
Ga-Eun Lee
Yong-Yeon ChoYong-Yeon Cho
Yong-Yeon Cho
Accumulating evidence demonstrates that the activity regulation of ELK3, a member of the E26 transformation-specific oncogene family, is critical to regulating cell proliferation, migration, and survival in human cancers. However, the molecular mechanisms of how ELK3 induces chemoresistance in prostate cancer (PCa) have not been elucidated. In this study, we found that SPOP and ELK3 are an interacting partner. The interaction between SPOP and ELK3 resulted in increased ELK3 ubiquitination and destruction, assisted by checkpoint kinase-mediated ELK3 phosphorylation. Notably, the modulation of SPOP-mediated ELK3 protein stability affected the c-Fos-induced cell proliferation and invasion of PCa cells. The clinical involvement of the SPOP-ELK3 axis in PCa development was confirmed by an immunohistochemical assay on 123 PCa tissues, with an inverse correlation between increased ELK3 and decreased SPOP being present in ~80% of the specimens. This observation was supported by immunohistochemistry analysis using a SPOP-mutant PCa specimen. Finally, docetaxel treatment induced cell death by activating checkpoint kinase- and SPOP-mediated ELK3 degradation, while SPOP-depleted or SPOP-mutated PCa cells showed cell death resistance. Notably, this observation was correlated with the protein levels of ELK3. Taken together, our study reveals the precise mechanism of SPOP-mediated degradation of ELK3 and provides evidence that SPOP mutations contribute to docetaxel resistance in PCa.

7 May 2021 in Palliative and Supportive Care
Verified
Journal Article
Closed access
PDF file
GLGuk Jin Lee
Guk Jin Lee
JGJi Hyun Gwak
Ji Hyun Gwak
MKMyoung Sim Kim
Myoung Sim Kim
MLMi Yeong Lee
Mi Yeong Lee
SKSeo Ree Kim
Seo Ree Kim
JJJong Youl Jin
Jong Youl Jin
Objective: The accurate estimation of expected survival in terminal cancer patients is important. The palliative performance scale (PPS) is an important factor in predicting survival of hospice patients. The purpose of this study was to examine how initial status of PPS and changes in PPS affect the survival of hospice patients in Korea.Method: We retrospectively examined 315 patients who were admitted to our hospice unit between January 2017 and December 2018. The patients were divided based on the PPS of ≥50% (group A) and ≤40% (group B). We performed survival analysis for factors associated with the length of survival (LOS) in group A. Based on the hospice team's weekly evaluation of PPS, we examined the effect of initial levels and changes in group A on the prognosis of patients who survived for 2 weeks or more.Results: At the time of admission to hospice, 265 (84.1%) patients were PPS ≥50%, and 50 (15.9%) were PPS ≤40%. The median LOS of PPS ≥50% and PPS ≤40% were 15 (2–158 days) and 9 (2–43 days), respectively. Male, gastrointestinal cancer, and lower initial PPS all predicted poor prognosis in group A. Male, gastrointestinal cancer, and a PPS change of 10% or greater, compared with initial status 1 week and 2 weeks of hospitalization, were all predictors of poor prognosis in group A patients who survived for 2 weeks or longer.Significance of results: Our research demonstrates the significance of PPS change at 1 week and 2 weeks, suggesting the importance of evaluating not only initial PPS but also change in PPS.

1 January 2023 in Journal of Gastric Cancer
Verified
Journal Article
Open access
PDF file
GLGuk Jin Lee
Guk Jin Lee
HKHyunho Kim
Hyunho Kim
SCSung Shim Cho
Sung Shim Cho
HPHyung Soon Park
Hyung Soon Park
HAHo Jung An
Ho Jung An
BSByoung Yong Shim
Byoung Yong Shim
Lee GJ, et al. J Gastric Cancer. 2023 Mar;23:e16. https://doi.org/10.5230/jgc.2023.23.e16

1 December 2021 in Korean Journal of Clinical Oncology
Verified
Journal Article
Open access
PDF file
SKSeo Ree Kim
Seo Ree Kim
SCSang Hoon Chun
Sang Hoon Chun
JJJong Youl Jin
Jong Youl Jin
TGTae Geun Gweon
Tae Geun Gweon
HLHayemin Lee
Hayemin Lee
GLGuk Jin Lee
Guk Jin Lee
There have been several reports of complications of small bowel lymphoma, such as bleeding, obstruction, and perforation, often require emergency surgery. It is hardly showed complications of bleeding and wound dehiscence for diffuse large B cell lymphoma with distal ileum involvement, which needed urgent surgery and medical management. A 65-year-old man with diffuse large B-cell lymphoma with distal ileum involvement experienced both intestinal bleeding and perforation during the course of treatment. As the patient was diagnosed with stage III disease, resection before chemotherapy was not considered due to the resulting delay in chemotherapy, which necessitated sufficient tissue healing. Chemotherapy is important when treating small bowel lymphoma, complications such as bleeding and perforation should always be considered for the treatment of small bowel lymphoma, and surgery is necessary in this situation. After surgery of the small bowel, subsequent chemotherapy could cause wound dehiscence and perforation; therefore, adequate recovery time should be given before chemotherapy.

26 March 2026 in Diabetes, Obesity and Metabolism
Verified
Journal Article
Open access
PDF file
GLGuk Jin Lee
Guk Jin Lee
SJSANG-HYUK JUNG
SANG-HYUK JUNG
JLJonghyun Lee
Jonghyun Lee
KMKi Won Moon
Ki Won Moon
PBPenn Medicine Biobank
Penn Medicine Biobank
DKDokyoon Kim
Dokyoon Kim
Aims: Type 2 diabetes mellitus (T2DM) has been inversely associated with prostate cancer (PrCa) risk. However, it remains unclear whether a polygenic risk score (PRS) for PrCa can effectively stratify risk among men with T2DM. The primary objective of this study was to assess whether a PrCa PRS predicts PrCa risk independently of T2DM status. The secondary objective was to evaluate potential mediating factors, including insulin‐like growth factor‐1 (IGF‐1) and sex hormones. Materials and Methods: We analysed data from over 140 000 men in the UK Biobank and Penn Medicine Biobank. A PrCa PRS was constructed using summary statistics from a large‐scale genome‐wide association study. Cox proportional hazards models were used to evaluate the association between PRS and incident PrCa, adjusting for relevant covariates and testing for interaction by T2DM status. Additionally, sex hormones and IGF‐1 levels were analysed to explore potential mediators. Results: T2DM was associated with a reduced incidence of PrCa. The PrCa PRS was significantly associated with PrCa risk regardless of T2DM status ( p < 0.001), and men in the highest PRS category exhibited the greatest risk, especially among those without T2DM. IGF‐1 levels were positively associated with PrCa risk among both diabetic and non‐diabetic men, while sex hormone levels showed no significant association in men with T2DM. Adjusting for testosterone and IGF‐1 did not attenuate the association between PRS and PrCa. Conclusions: PrCa PRS effectively stratifies risk among men with and without T2DM, highlighting the independent contribution of genetic susceptibility. Lower IGF‐1 levels in T2DM patients may partly mediate the reduced PrCa risk, suggesting a possible biological mechanism underlying these observations.

13 September 2021 in Research Square
Verified
Preprint
Open access
PDF file
SKSeo Ree Kim
Seo Ree Kim
SCSang Hoon Chun
Sang Hoon Chun
JJJong Youl Jin
Jong Youl Jin
TGTae-Geun Gweon
Tae-Geun Gweon
HLHayemin Lee
Hayemin Lee
GLGuk Jin Lee
Guk Jin Lee
Background: There have been several reports of complications of small bowel lymphoma, such as bleeding, obstruction, and perforation, which require emergency surgery. It is hardly showed complication of bleeding and wound dehiscence for diffuse large B cell lymphoma with distal ileum involvement, which needed urgent surgery and medical management. Chemotherapy is also important when treating small bowel lymphoma, but complications such as bleeding and perforation should always be kept in mind.Case presentation: A 65 year-old man with stage III diffuse large B-cell lymphoma of the activated-B cell (ABC) type with distal ileum involvement experienced both intestinal bleeding and perforation during the course of treatment. As the patient was diagnosed with stage III disease, resection before chemotherapy was not considered due to the resulting delay in chemotherapy, which necessitated sufficient tissue healing. Conclusion: As shown in this case, complications such as bleeding and perforation should always be considered for the treatment of small bowel lymphoma, and surgery is necessary in this situation. After surgery of the small bowel, subsequent chemotherapy could cause the wound dehiscence and perforation; therefore, adequate recovery time should be given before chemotherapy.